DK2924053T3 - Glycosyleret linker, forbindelse, der indeholder glycosyleret linker-del og fysiologisk aktiv stofdel eller salt deraf, og fremgangsmåder til fremstilling af forbindelsen eller saltet deraf - Google Patents

Glycosyleret linker, forbindelse, der indeholder glycosyleret linker-del og fysiologisk aktiv stofdel eller salt deraf, og fremgangsmåder til fremstilling af forbindelsen eller saltet deraf Download PDF

Info

Publication number
DK2924053T3
DK2924053T3 DK13857593.1T DK13857593T DK2924053T3 DK 2924053 T3 DK2924053 T3 DK 2924053T3 DK 13857593 T DK13857593 T DK 13857593T DK 2924053 T3 DK2924053 T3 DK 2924053T3
Authority
DK
Denmark
Prior art keywords
links
glycosyled
glycosylated
salts
preparation
Prior art date
Application number
DK13857593.1T
Other languages
English (en)
Inventor
Hirofumi Ochiai
Kenta Yoshida
Original Assignee
Glytech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glytech Inc filed Critical Glytech Inc
Application granted granted Critical
Publication of DK2924053T3 publication Critical patent/DK2924053T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K17/00Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02Peptides being immobilised on, or in, an organic carrier
    • C07K17/10Peptides being immobilised on, or in, an organic carrier the carrier being a carbohydrate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/549Sugars, nucleosides, nucleotides or nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08HDERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
    • C08H1/00Macromolecular products derived from proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/62Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
DK13857593.1T 2012-11-22 2013-10-30 Glycosyleret linker, forbindelse, der indeholder glycosyleret linker-del og fysiologisk aktiv stofdel eller salt deraf, og fremgangsmåder til fremstilling af forbindelsen eller saltet deraf DK2924053T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012256947 2012-11-22
PCT/JP2013/079408 WO2014080730A1 (ja) 2012-11-22 2013-10-30 糖鎖付加リンカー、糖鎖付加リンカー部分と生理活性物質部分とを含む化合物またはその塩、及びそれらの製造方法

Publications (1)

Publication Number Publication Date
DK2924053T3 true DK2924053T3 (da) 2020-12-14

Family

ID=50775917

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13857593.1T DK2924053T3 (da) 2012-11-22 2013-10-30 Glycosyleret linker, forbindelse, der indeholder glycosyleret linker-del og fysiologisk aktiv stofdel eller salt deraf, og fremgangsmåder til fremstilling af forbindelsen eller saltet deraf

Country Status (8)

Country Link
US (1) US9708413B2 (da)
EP (1) EP2924053B1 (da)
JP (1) JP6211533B2 (da)
KR (1) KR102227918B1 (da)
CN (1) CN104918962B (da)
DK (1) DK2924053T3 (da)
TW (1) TWI634127B (da)
WO (1) WO2014080730A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI618697B (zh) 2015-11-03 2018-03-21 財團法人工業技術研究院 化合物、連接子-藥物、及配體-藥物耦合體
EP3770180A4 (en) * 2018-03-22 2021-12-22 Mochida Pharmaceutical Co., Ltd. ALGIC ACID DERIVATIVE BONDED TO A NON-STEROIDAL ANTI-INFLAMMATORY COMPOUND
JP7437578B2 (ja) * 2019-03-20 2024-02-26 国立大学法人東北大学 新規オピオイドペプチド、その糖鎖付加体及びそれらを含む医薬組成物
CN113501889A (zh) * 2021-07-06 2021-10-15 郑州大学 一种三七多糖阳离子衍生物的制备方法及其应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0778081B2 (ja) * 1990-07-19 1995-08-23 静岡大学長 機能化高分子の合成方法
JP2604930B2 (ja) * 1990-12-14 1997-04-30 株式会社ディ・ディ・エス研究所 ヒアルロン酸およびコンドロイチン誘導体
JP2527885B2 (ja) * 1992-09-02 1996-08-28 株式会社ディ・ディ・エス研究所 ヘパリン誘導体
ATE199908T1 (de) * 1996-12-16 2001-04-15 Nederlanden Staat Verfahren zur kupplung von polysacchariden und proteinen
JP2001302695A (ja) 2000-04-20 2001-10-31 Asahi Kasei Corp Gln結合型糖鎖付加カルシトニン誘導体
US6441293B1 (en) 2000-04-28 2002-08-27 Labarbera Anthony System for generating percussion sounds from stringed instruments
CA2451971C (en) 2001-06-19 2010-09-07 Otsuka Chemical Co., Ltd. Process for producing sugar chain asparagine derivative
US20030096299A1 (en) 2001-07-09 2003-05-22 Valerie Wittamer Natural ligand of G protein coupled receptor ChemR23 and uses thereof
US7943763B2 (en) 2002-07-05 2011-05-17 Otsuka Chemical Holdings Co., Ltd. Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides
TWI335920B (en) 2002-12-24 2011-01-11 Yasuhiro Kajihara Sugar chain asparagine derivatives, sugar chain asparagine and sugar chain and manufacture thereof
EP1577324B1 (en) 2002-12-26 2014-08-13 Yasuhiro Kajihara Three-branched sugar-chain asparagine derivatives, the sugar-chain asparagines, the sugar chains, and processes for producing these
CA2514337C (en) 2003-02-04 2010-07-13 Otsuka Chemical Co., Ltd. Process for producing sugar chain asparagine derivative
CA2521784C (en) 2003-04-08 2012-03-27 Yeda Research And Development Co. Ltd. Reversible pegylated drugs
JP4555823B2 (ja) 2003-07-11 2010-10-06 セラヴァンス, インコーポレーテッド 架橋されたグリコペプチド−セファロスポリン抗生物質
JPWO2005007694A1 (ja) 2003-07-16 2007-09-20 株式会社グリーンペプタイド HER2/neuペプチドおよびその治療上の用途
CA2533849C (en) 2003-07-28 2013-07-02 Otsuka Chemical Co., Ltd. Aminated complex-type sugar chain derivatives and process for the production thereof
JP2007501870A (ja) * 2003-08-08 2007-02-01 フレゼニウス・カビ・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ヒドロキシアルキルデンプンとg−csfの複合体
CN1832762B (zh) * 2003-08-08 2012-09-05 弗雷泽纽斯卡比德国有限公司 羟烷基淀粉与g-csf的偶联物
CN1310898C (zh) 2004-01-19 2007-04-18 中国人民解放军军事医学科学院毒物药物研究所 紫杉醇水溶性衍生物
MXPA06010764A (es) 2004-03-23 2006-12-15 Amgen Inc Metodos y composiciones de proteinas quimicamente modificadas.
JPWO2005095331A1 (ja) 2004-03-31 2008-02-21 塩野義製薬株式会社 糖鎖−ペプチド結合剤
TW200643033A (en) * 2005-03-08 2006-12-16 Chugai Pharmaceutical Co Ltd Conjugate of water-soluble modified hyaluronic acid and glp-1 analogue
TWI342880B (en) 2005-07-19 2011-06-01 Otsuka Chemical Co Ltd Method for producing sugar chain derivatives, and sugar chain derivatives
CA2696615A1 (en) * 2007-06-19 2008-12-24 Otsuka Chemical Co., Ltd. Oligosaccharide chain added glp-1 peptide
ES2904673T3 (es) * 2008-02-01 2022-04-05 Ascendis Pharma As Profármaco que comprende un conjugado de fármaco-enlazador.
JP2009242372A (ja) 2008-03-11 2009-10-22 Yokohama City Univ 均一な糖鎖構造を有するエリスロポエチン誘導体
RU2543157C2 (ru) 2008-06-17 2015-02-27 Глитек,Инк. Гликозилированный пептид glp-1
CA2734124C (en) 2008-08-19 2018-06-05 Otsuka Chemical Co., Ltd. Glycoprotein production method and screening method
JP2010229093A (ja) 2009-03-27 2010-10-14 Banyu Pharmaceut Co Ltd 新規ChemerinRアゴニスト
US20120264684A1 (en) * 2009-10-30 2012-10-18 Yasuhiro Kajihara Glycosylated Form of Antigenic GLP-1 Analogue

Also Published As

Publication number Publication date
TW201427999A (zh) 2014-07-16
US20150299337A1 (en) 2015-10-22
US9708413B2 (en) 2017-07-18
KR20150102003A (ko) 2015-09-04
KR102227918B1 (ko) 2021-03-15
JPWO2014080730A1 (ja) 2017-01-05
WO2014080730A1 (ja) 2014-05-30
JP6211533B2 (ja) 2017-10-11
CN104918962B (zh) 2017-12-19
TWI634127B (zh) 2018-09-01
EP2924053B1 (en) 2020-11-11
EP2924053A4 (en) 2016-08-24
CN104918962A (zh) 2015-09-16
EP2924053A1 (en) 2015-09-30

Similar Documents

Publication Publication Date Title
NO2018026I2 (no) Bictegravir eller et farmasøytisk akseptabelt salt derav, spesielt natriumbictegravir
DK2900752T3 (da) Fugemasse, vægenhed og fremgangsmåder og produkter relateret dertil
CO7061071A2 (es) Procesos para la preparación de (s)-1-(3-etoxi-4-metoxifenil)-2-metansulfoniletilamina
DK2723887T3 (da) Systemer, fremgangsmåder og indretinger til at opnå glykæmisk ligevægt
DK2841429T3 (da) Tetrazolinonforbindelser og anvendelse deraf som pesticider
DK2611785T3 (da) N-(tetrazol-5yl)- og n- (triazol-5-yl) arylcarboxylsyreamider og deres anvendelse som herbicider
ZA201503753B (en) Pyrrole sulfonamide derivative, preparation method for same, and medical application thereof
CO6781519A2 (es) Equipo y procedimiento para exploración, diagnóstico y terapia de problemas funcionales de la visión
DK2900645T3 (da) Herbicidt aktive 3-phenylisoxazolinderivater
DK2773633T3 (da) Heterocykliske forbindelser, medikamenter indeholdende forbindelserne, anvendelse deraf og fremgangsmåder til fremstilling deraf.
DK2809318T3 (da) Ammoniumholdige sulfonsyre-, phosphonsyre- og carboxylsyrederivater og disses medicinske anvendelse
DK2920240T3 (da) Fremgangsmåde til fremstilling af en vandig opløsning af chitosan, chitosansammensætning, chitosanaerosol, fremgangsmåde til fremstilling af en chitosanhydrogelmembran og fremgangsmåde til fremstilling af et chitosan-protein-biopolymermateriale
CO6910193A2 (es) Derivados de anilina, su preparación y su aplicación terapéutica
DK2736888T3 (da) 3-heteroaroylaminopropionsyrederivater og deres anvendelse som farmaceutika
CU20130003A7 (es) Procedimiento de preparacion de la sal de l-arginina de perindoprilo.
CO6811865A2 (es) Método de tratamiento de la fiebre dengue
DK2864496T4 (da) Euglobulin-baseret fremgangsmåde til bestemmelse af den biologiske aktivitet af defibrotid
CO7020857A2 (es) Procedimiento para la preparación de complejos de 68ga
DK2786757T3 (da) 2-substitueret oleanolsyre-derivat, fremgangsmåde til fremstilling af samme, og anvendelse deraf
CO6811857A2 (es) Derivados de 2-amino-3(imidazol-2-il)-piridin-4-ona, preparación de los mismos y uso terapéutico de los mismos
BR112014030277A2 (pt) sistema médico
BR112015003116A2 (pt) preparação farmacêutica sólida contendo levotiroxina
DK2924053T3 (da) Glycosyleret linker, forbindelse, der indeholder glycosyleret linker-del og fysiologisk aktiv stofdel eller salt deraf, og fremgangsmåder til fremstilling af forbindelsen eller saltet deraf
DK2871184T3 (da) Benzodioxolderivat og fremgangsmåde til fremstilling og anvendelse deraf
EP2926829A4 (en) BINDED GLUCIDINE CHAIN, COMPOUND CONTAINING BINDED GLUCIDIC CHAIN BINDER AND PHYSIOLOGICALLY ACTIVE SUBSTANCE OR SALT THEREOF, AND PROCESS FOR PRODUCING THE SAME